Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
Authors:
Open Access
- 8 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 881722
Abstract
The aberrant protein disulfide isomerase A5 (PDIA5) expression was relevant to the poor prognosis of patients with human cancers. However, its relationship with the epigenetic and genetic alterations and its effect on tumor immunity is still lacking. In the present study, we comprehensively analyzed the immune infiltration role of PDIA5 in human cancers based on large-scale bioinformatics analyses and in vitro experiments. Obvious DNA methylation and moderate alteration frequency of PDIA5 were observed in human cancers. The expression level of PDIA5 was significantly correlated with infiltrated immune cells, immune pathways, and other immune signatures. We found that cancer cells and macrophages exhibited high PDIA5 expression in human cancers using the single-cell RNA sequencing analysis. We also demonstrated the interaction between PDIA5 and immune cells in glioblastoma multiforme (GBM). Multiplex immunofluorescence staining showed the upregulated expression level of PDIA5 and the increased number of M2 macrophage markers-CD163 positive cells in pan-cancer samples. Notably, PDIA5 silencing resulted in upregulated expression of PD-L1 and SPP1 in U251 cells. Silencing of PDIA5 in hepG2 cells, U251 cells, and PC3 cells contributed to a decline in their ability of proliferation, clone formation, and invasion and inhibited the migration of cocultured M2 macrophages. Additionally, PDIA5 also displayed predictive value in the immunotherapy response of both murine and human cancer cohorts. Overall, our findings indicated that PDIA5 might be a potential target for immunotherapies in cancers.Keywords
This publication has 67 references indexed in Scilit:
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaScience, 2014
- Endoplasmic Reticulum Stress-Activated Transcription Factor ATF6α Requires the Disulfide Isomerase PDIA5 To Modulate ChemoresistanceMolecular and Cellular Biology, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Structure of the Non-Catalytic Domain of the Protein Disulfide Isomerase-Related Protein (PDIR) Reveals Function in Protein BindingPLOS ONE, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerProceedings of the National Academy of Sciences, 2009
- Disulfide Formation in the ER and Mitochondria: Two Solutions to a Common ProcessScience, 2009
- The human PDI family: Versatility packed into a single foldBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Molecular cloning of the cDNA encoding a novel protein disulfide isomerase‐related protein (PDIR)FEBS Letters, 1995